Wednesday, December 23, 2020

HHS, DOD Collaborate With Merck to Continue the Development and Large-Scale Manufacturing of Investigational COVID-19 Treatment

U.S. Department of Defense Releases
IMMEDIATE RELEASE
HHS, DOD Collaborate With Merck to Continue the Development and Large-Scale Manufacturing of Investigational COVID-19 Treatment
Dec. 23, 2020
The Department of the Health and Human Services and the Defense Department jointly announced an agreement with Merck to support advanced development and large-scale manufacturing of the their investigational therapeutic MK-7110 to treat hospitalized patients with severe or critical COVID-19.

NEWSROOM PRODUCTS

Press Advisories   Releases   Transcripts

Speeches   Publications   Contracts
Visit Defense dot gov
OUR STORY   KNOW YOUR MILITARY   ASK US   LATEST STORIES
Facebook   Twitter   Instagram   Youtube

Unsubscribe | Contact Us
This email was sent to stevenmagallanes520.nims@blogger.com using GovDelivery Communications Cloud on behalf of: U.S. Department of Defense
1400 Defense Pentagon Washington, DC 20301-1400
at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Page List

Blog Archive

Search This Blog

re: 2024 Election Day

Hey, I need your help immediately, but you can't tell anybody about this!  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌...